E
Edle Ravndal
Researcher at University of Oslo
Publications - 57
Citations - 1717
Edle Ravndal is an academic researcher from University of Oslo. The author has contributed to research in topics: Substance abuse & Pregnancy. The author has an hindex of 21, co-authored 57 publications receiving 1558 citations. Previous affiliations of Edle Ravndal include Norwegian Institute for Alcohol and Drug Research.
Papers
More filters
Journal ArticleDOI
Minimization of childhood maltreatment is common and consequential: results from a large, multinational sample using the childhood trauma questionnaire
Kai MacDonald,Michael L. Thomas,Andres F Sciolla,Beacher Schneider,Katherine Pappas,Gijs Bleijenberg,Martin Bohus,Bradley Bekh,Bradley Bekh,Linda L. Carpenter,Alan Carr,Udo Dannlowski,Martin J. Dorahy,Claudia Fahlke,Ricky Finzi-Dottan,Tobi Karu,Arne Gerdner,Heide Glaesmer,Hans J. Grabe,Marianne Heins,Dianna T. Kenny,Daeho Kim,Hans Knoop,Jill Lobbestael,Christine Lochner,Grethe Lauritzen,Edle Ravndal,Shelley A. Riggs,Vedat Sar,Ingo Schäfer,Nicole Schlosser,Melanie L. Schwandt,Murray B. Stein,Claudia Subic-Wrana,Mark Vogel,Katja Wingenfeld +35 more
TL;DR: Investigation of 3 aspects of minimization, as defined by the Childhood Trauma Questionnaire's MD scale, suggested that a minimizing response bias—as detected by the MD subscale—has a small but significant moderating effect on the CTQ’s discriminative validity.
Journal ArticleDOI
Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants.
Gabrielle K. Welle-Strand,Svetlana Skurtveit,Lauren M. Jansson,Brittelise Bakstad,Lisa Bjarkø,Edle Ravndal +5 more
TL;DR: To examine the rate andduration of breastfeeding in a cohort of women in opioid maintenance treatment (OMT) in Norway, as well as the effect of breastfeeding on the incidence and duration of neonatal abstinence syndrome (NAS).
Journal ArticleDOI
Opioid Maintenance Treatment during Pregnancy: Occurrence and Severity of Neonatal Abstinence Syndrome
TL;DR: Maternal methadone/buprenorphine dose predicted neither the occurrence nor the need for NAS treatment for the infant, as well as the mean number of cigarettes consumed correlated significantly with NAS treatment duration for the methad one group.
Journal ArticleDOI
Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
Gabrielle K. Welle-Strand,Svetlana Skurtveit,Svetlana Skurtveit,Hendrée E. Jones,Helge Waal,Brittelise Bakstad,Lisa Bjarkø,Edle Ravndal +7 more
TL;DR: Both methadone and buprenorphine are acceptable medications for the use in pregnancy, in line with previous studies, and should be considered as the drug of choice, due to more favorable neonatal growth parameters.
Journal ArticleDOI
Mortality among drug users after discharge from inpatient treatment: An 8-year prospective study
Edle Ravndal,Ellen J. Amundsen +1 more
TL;DR: The elevated risk of dying from overdose within the first 4 weeks of leaving medication-free inpatient treatment is so dramatic that preventive measures should be taken.